Archives
-
How Viability Assays Shape mRNA-LNP Toxicity Readouts
2026-10-09
A 2025 review places MTT, LDH, AlamarBlue, flow-cytometry viability, impedance, and inflammatory readouts within the broader preclinical evaluation of mRNA lipid nanoparticles. In a cited HepG2 comparison, an MC3-based formulation showed greater cytotoxicity than SM-102-based formulations with both MTT and LDH, while the reported assay conclusions did not differ. Separately, SM-102 LNPs produced higher in vitro protein expression and T-cell proliferation than ALC-0315 and Dlin-MC3-DMA LNPs, but zebrafish and mouse studies showed nearly identical protein expression and no significant differences in antigen-specific immune responses.
-
CCK-8 in Vaccine-Induced Splenocyte Proliferation
2026-10-07
Cui et al. used CCK-8 absorbance as a relative proliferation readout after ex vivo T-SGR antigen restimulation of splenocytes from vaccinated C57BL/6 mice. Both the T-SGR mRNA-LNP group and the recombinant-protein group showed higher relative proliferation than the PBS control, but the study did not report a significant CCK-8 difference between the two vaccine platforms. The application supports CCK-8 as one functional immune-readout component, not as a validation against WST-8, resazurin, MTS, LDH release, or staining methods.
-
What Clonogenic Survival Adds to Radioprotection Studies
2026-10-05
In this radioprotection study, Dsup-expressing human oral epithelial and Caco-2 colorectal epithelial cells formed more colonies after irradiation than GFP-control mRNA nanoparticle-treated cells. Compared with WR-1065, Dsup-GFP mRNA nanoparticles showed comparable protection at the highest tested comparator level and greater protection at lower comparator levels. The findings illustrate how clonogenic survival adds a long-term proliferation endpoint to DNA-damage measurements, but they do not validate CCK-8, WST-8, resazurin, MTS, LDH, or other viability assays.
-
Reading Cytotoxicity Signals in Engineered Pyroptosis
2026-10-02
In HEK293T cells using EGFP as the target RNA, DAMAGE activation produced more LDH release and PI-positive cells, but fewer EGFP-positive cells and a lower ATP-based viability signal, than non-targeting controls. In RSV experiments, lowering RSV-N RNA abundance lowered PI positivity and LDH release relative to higher-trigger conditions; in HeLa cells targeting endogenous HPV18 RNA, both signals increased over time relative to non-targeting controls and peaked at 36 hours. The study therefore supports orthogonal interpretation of lytic-cell-death readouts, not validation of WST-8/CCK-8, resazurin, or MTS assay performance.
-
CCK-8 Readouts of DSF-Loaded LNP Cytotoxicity
2026-09-30
In BV2 microglia, DSF-loaded lipid nanoparticles maintained higher CCK-8 viability than free disulfiram across 1–20 μg/mL and increased the 48-hour IC50 from 6.9 to 28.7 μg/mL. CNTF@LNP, CNTF/DSF@LNP, saCNTF@LNP, and saCNTF/DSF@LNP all showed high CCK-8 viability across 0.5–4 μg/mL CNTF-equivalent concentrations at 24 and 48 hours. In a separate nigericin-induced pyroptosis model, DSF@LNP and saCNTF/DSF@LNP performed equivalently by EthD staining and LDH release, whereas free DSF provided only partial protection. The study is therefore an application case for interpreting formulation cytotoxicity, not a validation of CCK-8 assay superiority or a commercial assay product.
-
KANPEI mRNA Carriers: Cell Viability Evidence
2026-09-28
This mRNA-carrier study used a CCK Cell Viability Assay Kit as a supporting readout of cytotoxicity, alongside luciferase expression tests. KANPEI-treated cells retained higher reported viability than PEI 25 kDa under the tested conditions; the paper does not compare viability-assay methods or establish that the kit was specifically CCK-8.
-
Fritillaria Alkaloids Attenuate LPS-Driven Inflammation
2026-09-24
A study of four Fritillaria isosteroidal alkaloids found reduced inflammatory readouts in LPS-stimulated RAW 264.7 cells, with ebeiedinone and peimisine also showing protective effects in a rat acute lung injury model. The findings connect these effects with changes in MyD88- and TRIF-associated signaling, while leaving direct molecular targets and clinical relevance to be established.
-
Cell Counting Kit-8 (CCK-8) Plus Protocol
2026-09-21
Cell Counting Kit-8 (CCK-8) Plus, SKU K2268, provides a rapid WST-8-based readout for viable-cell-associated metabolic activity in proliferation, cytotoxicity, and drug screening workflows. It should be interpreted as a dehydrogenase-linked viability signal within a validated linear range, not as a direct cell count or standalone proof of cell death mechanism.
-
Luminescent ATP Viability Assay for Ferroptosis
2026-09-21
Ferroptosis research increasingly depends on distinguishing pathway activation from the final loss of viable cells. This thought-leadership guide shows how ATP-based luciferase luminescence detection can strengthen translational cytotoxicity workflows while clarifying what the signal can—and cannot—reveal about the STING1–CAV2, mitochondrial zinc, and reactive oxygen species biology described in the anchor study.
-
Dual-Action Inhibitors Rewire p38α Dephosphorylation
2026-09-20
The reference preprint shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also reshape the activation loop to accelerate WIP1-mediated dephosphorylation. Structural and biochemical results introduce kinase-state control as a potential route to improve inhibitor potency and specificity, while also defining important limits for translating purified-protein findings into cellular research.
-
UBE2T–SOCS2–JAK/STAT3 Signaling in PTC
2026-09-19
A February 2026 study identifies UBE2T as a driver of papillary thyroid carcinoma aggressiveness and links its effects to SOCS2 destabilization and JAK/STAT3 activation. The findings provide a mechanistic framework for studying invasion and lymph node metastasis, while also highlighting the need to distinguish growth, viability, and invasion phenotypes in follow-up experiments.
-
Annexin V-FITC/7-AAD Apoptosis Kit Guide
2026-09-18
The Annexin V-FITC/7-AAD Apoptosis Kit provides a rapid dual-fluorescence readout for separating viable, early apoptotic, late apoptotic, and necrotic cell populations. It is suitable for flow cytometry or fluorescence microscopy in cell viability and cytotoxicity workflows, but it should not be used alone to identify a specific apoptotic signaling mechanism.
-
EdU Imaging Kits (488) for NSCLC Cell-Cycle Studies
2026-09-18
Turn S-phase entry into a clean, image-ready endpoint for treatment-response studies in NSCLC and other proliferating cell models. EdU Imaging Kits (488) combine click-chemistry labeling with nuclear staining, enabling faster proliferation analysis while preserving morphology and antigen-binding sites.
-
Porcupine Inhibition for Severe Sclerosteosis
2026-09-17
Dreyer and colleagues identify PORCN inhibition with LGK974 as a potential pharmacological strategy for sclerosteosis, a severe high-bone-mass disorder caused by loss of functional sclerostin. Their combined cell, mouse, and mechanoadaptation experiments show reduced osteoblast activity and skeletal overgrowth, while also revealing sex-dependent differences in target engagement.
-
Ceruletide as a Mechanistic Pancreatic Fibrosis Tool
2026-09-17
Ceruletide, also known as Caerulein, is more than a pancreatitis inducer: it can function as a controlled secretagogue stressor for connecting pancreatic injury, stellate-cell remodeling, and antifibrotic mechanisms. This article presents an assay strategy grounded in recent MFGE8–ANXA1–SMAD2/3 research.